Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 120.51
  • 1.85  -1.51%
    Today's Change
  • 122.36
    Previous Close
  • Today
    52 Week Low - High
11:03 am ET 1/28/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding799 million
Market Cap$96 billion
Return on Equity ttm27.44%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm2.177
EPS: Year Est. 12/14 ttm3.706
EPS: Quarterly Actual 9/14 0.97
EPS: Quarterly Est. 12/14 1.01
Price/Earnings ttm55.31
Relative Price/Earnings3.100
Earnings Growth Rate3.55
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$6 billion
Net Income$1 billion
Total Assets$13 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!